18F-SynVesT-1与18F-FDG定量PET显像在MRI阴性儿童局灶性皮质发育不良II型术前评估中的应用
该前瞻性研究纳入17例MRI阴性的FCD II型患儿,术前行18F-SynVesT-1与18F-FDG PET,并基于健康对照进行SPM定量分析(QPET),评估各方法定位致痫灶的效能并构建多变量预测模型。结果显示,基于双示踪PET/QPET的多变量预测模型AUC达0.996(灵敏度100.0%,特异度96.6%),视觉评估联合QPET可能提高定位致痫灶的灵敏度和特异度。
要点
- 18F-SynVesT-1 PET的AUC为0.908,高于18F-FDG PET的0.861。
- 多变量预测模型AUC为0.996(灵敏度100.0%,特异度96.6%)。
- 视觉评估联合QPET可能提高MRI阴性FCD II致痫灶定位效能。
核心结论
- 基于18F-SynVesT-1与18F-FDG PET/QPET评估的多变量预测模型有望无创识别MRI阴性FCD II患儿的致痫区。
- 视觉评估与QPET联合可能提高定位致痫灶的灵敏度和特异度,并获得更佳手术结局。
研究设计与样本
- 前瞻性纳入17例MRI阴性FCD II患儿,术前均行18F-SynVesT-1与18F-FDG PET。
- QPET扫描采用统计参数映射(SPM)以健康对照为参照进行分析。
- 评估各方法定位致痫灶的灵敏度、特异度、阳性预测值(PPV)、阴性预测值(NPV)和曲线下面积(AUC),并构建基于双示踪PET/QPET评估的多变量预测模型。
主要发现
- 18F-FDG PET的AUC为0.861(灵敏度94.1%,特异度78.2%,PPV 38.1%,NPV 98.9%)。
- 18F-SynVesT-1 PET的AUC为0.908(灵敏度82.4%,特异度99.2%,PPV 93.3%,NPV 97.5%)。
- 18F-FDG QPET较视觉评估灵敏度(76.5%)和NPV(96.6%)更低,但特异度(95.0%)和PPV(68.4%)更高。
- 18F-SynVesT-1 QPET较视觉评估灵敏度(94.1%)和NPV(99.1%)更高,但特异度(97.5%)和PPV(84.2%)更低。
- 多变量预测模型AUC最高(0.996),灵敏度100.0%,特异度96.6%,PPV 81.0%,NPV 100%。
关键数值与推荐
- 18F-FDG PET:AUC 0.861,灵敏度94.1%,特异度78.2%,PPV 38.1%,NPV 98.9%。
- 18F-SynVesT-1 PET:AUC 0.908,灵敏度82.4%,特异度99.2%,PPV 93.3%,NPV 97.5%。
- 18F-FDG QPET:灵敏度76.5%,NPV 96.6%,特异度95.0%,PPV 68.4%。
- 18F-SynVesT-1 QPET:灵敏度94.1%,NPV 99.1%,特异度97.5%,PPV 84.2%。
- 多变量预测模型:AUC 0.996,灵敏度100.0%,特异度96.6%,PPV 81.0%,NPV 100%。
临床怎么用
- 多变量预测模型基于18F-SynVesT-1与18F-FDG PET/QPET评估,有望用于无创识别MRI阴性FCD II患儿的致痫区。
- 视觉评估联合QPET可能提高致痫灶定位的灵敏度和特异度,并获得更佳手术结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: MRI-negative children with focal cortical dysplasia type II (FCD II) are one of the most challenging cases in surgical epilepsy management. We aimed to utilize quantitative positron emission tomography (QPET) analysis to complement [18F]SynVesT-1 and [18F]FDG PET imaging and facilitate the localization of epileptogenic foci in pediatric MRI-negative FCD II patients. METHODS: We prospectively enrolled 17 MRI-negative children with FCD II who underwent [18F]SynVesT-1 and [18F]FDG PET before surgical resection. The QPET scans were analyzed using statistical parametric mapping (SPM) with respect to healthy controls. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of [18F]SynVesT-1 PET, [18F]FDG PET, [18F]SynVesT-1 QPET, and [18F]FDG QPET in the localization of epileptogenic foci were assessed. Additionally, we developed a multivariate prediction model based on dual trace PET/QPET assessment. RESULTS: The AUC values of [18F]FDG PET and [18F]SynVesT-1 PET were 0.861 (sensitivity = 94.1%, specificity = 78.2%, PPV = 38.1%, NPV = 98.9%) and 0.908 (sensitivity = 82.4%, specificity = 99.2%, PPV = 93.3%, NPV = 97.5%), respectively. [18F]FDG QPET showed lower sensitivity (76.5%) and NPV (96.6%) but higher specificity (95.0%) and PPV (68.4%) than visual assessment, while [18F]SynVesT-1 QPET exhibited higher sensitivity (94.1%) and NPV (99.1%) but lower specificity (97.5%) and PPV (84.2%). The multivariate prediction model had the highest AUC value (AUC = 0.996, sensitivity = 100.0%, specificity = 96.6%, PPV = 81.0%, NPV = 100%). CONCLUSIONS: The multivariate prediction model based on [18F]SynVesT-1 and [18F]FDG PET/QPET assessments holds promise in noninvasively identifying epileptogenic regions in MRI-negative children with FCD II. Furthermore, the combination of visual assessment and QPET may improve the sensitivity and specificity of diagnostic tests in localizing epileptogenic foci and achieving a preferable surgical outcome in MRI-negative FCD II.
引用
- Xiao L, Yang J, Zhu H, et al. [18F]SynVesT-1 and [18F]FDG quantitative PET imaging in the presurgical evaluation of MRI-negative children with focal cortical dysplasia type II. Eur J Nucl Med Mol Imaging. 2024. PMID: 38182838. doi:10.1007/s00259-024-06593-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。